Our data indicate that the expression of (p)EGFR and HER2 is largely an intrinsic feature of a tumor cell, while the in vivo expression of activated kinases of important cell signaling pathways can be substantially affected by the tumor microenvironment. The gene discussed is ERBB2; the disease is neoplasm.